N-(4-methoxyphenyl)-2-methylbutanamide | 335397-54-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-methoxyphenyl)-2-methylbutanamide
• CAS: 335397-54-1
• 化学式: C₁₂H₁₇NO₂
• mdl: MFCD02625509
• 分子量: 207.272
• InChiKey: WEEDBKYAROGPRB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-(4-methoxyphenyl)-2-methylbutanamide 、 环己甲腈 在 2-氯吡啶 、 三氟甲磺酸酐 作用下， 以 二氯甲烷 为溶剂， 反应 0.33h， 以85%的产率得到2-(sec-butyl)-4-cyclohexyl-6-methoxyquinazoline
  参考文献：
  名称：

  合成嘧啶衍生物的新策略。

  摘要：

  描述了嘧啶合成的最新进展。涉及NCN片段与1，3-二羰基衍生物缩合的常规策略的修改仍然是当前文献中的共同主题。其他方法，包括NC片段缩合策略，提供了能够分子内环化和形成嘧啶衍生物的反应性中间体。这些最近开发的方法为氮杂杂环合成提供了宝贵的补充。

  DOI：

  10.1002/chem.200800014

文献信息

• PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE AS JANUS KINASE INHIBITOR
  申请人：Incyte Holdings Corporation

  公开号：EP3466953A1

  公开（公告）日：2019-04-10

  The present invention provides the use of 3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile in the preparation of a medicament for use in the treatment of graft versus host disease.

  本发明提供了 3-环戊基-3-[4-(7H-吡咯并[2,3-]嘧啶-4-基)-1H-吡唑-1-基]丙腈在制备用于治疗移植物抗宿主疾病的药物中的用途。
• IDO inhibitors
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US10167254B2

  公开（公告）日：2019-01-01

  There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

  本发明公开了调节或抑制吲哚胺-2,3-二氧化酶（IDO）酶活性的化合物、含有上述化合物的药物组合物以及利用本发明化合物治疗增殖性疾病（如癌症、病毒感染和/或炎症性疾病）的方法。
• Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US10399932B2

  公开（公告）日：2019-09-03

  There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

  本发明公开了调节或抑制吲哚胺-2,3-二氧化酶（IDO）酶活性的式(I)化合物、含有所述化合物的药物组合物以及利用本发明化合物治疗增殖性疾病（如癌症、病毒感染和/或炎症性疾病）的方法。
• Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US10695328B2

  公开（公告）日：2020-06-30

  The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

  本发明提供了式 (I) 的化合物： 或其立体异构体，或其药学上可接受的盐，其中所有变量如本文所定义。这些化合物是单酰基甘油酰基转移酶 2 型（MGAT2）抑制剂，可用作药物。
• NEGATIVE PHOTOSENSITIVE INSULATING RESIN COMPOSITION AND METHOD FOR PATTERNING USING THE SAME
  申请人：Maeda Katsumi

  公开号：US20110281217A1

  公开（公告）日：2011-11-17

  This invention relates to a negative photosensitive insulating resin composition characterized in that the composition comprises an alkali-soluble polymer having at least one repeating constitutional unit represented by the following general formula (1), a cross-linker and a photo-acid generator. The negative photosensitive insulating resin composition provides a film having excellent properties such as heat resistance, mechanical properties and electric properties, and can be alkali-developed to achieve high resolution. (In the formula, R 1 represents a hydrogen atom or a methyl group, and R 2 to R 5 represent, independently each other, a hydrogen atom or a hydrocarbon group having 1 to 4 carbon atoms.)